The company had received approvals from the US Food and Drug Administration earlier.
The drug is the generic equivalent of Tarot Pharma’s Topicort, which had US sales of $38 million per year.
The drug is used for relief of the “inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.” Dermatosesa refers to lesions or eruptions of the skin that can be acute or chronic.
Lupin is the 6 largest generics pharmaceutical company by sales globally and the second biggest pharma company in India.
It manufactures branded & generic formulations, biotechnology products and APIs or active pharmaceutical ingredients. It focuses on Cardiovascular, Diabetology, Asthma, Pediatric, CNS, Gl, Anti-infective and NSAID space and has sales of 171,198 million (USD 2.55 bilion) per year.